Emerging Infectious Disease Diagnostics: Markets and Trends

Emerging Infectious Disease Diagnostics: Markets and Trends

Why is it important to examine the world of emerging infectious diseases? In a 2015 TED Talk, Microsoft creator Bill Gates warned that there was a lack of preparation for a viral epidemic. He predicted that it would be “microbes, not missiles” that would cause significant harm to humans. Events in recent years have proven him right. Outbreaks of infections such as Zika and Ebola, the MERS threat, the SARS outbreak, the threat of TB and influenza epidemics, and HIV and STD’s uncontrolled march across continents have shown healthcare professionals that one can never remain complacent. Viral and bacterial pathogens are like a cat; they always come back and sometimes with more vigor than expected.

In light of the COVID-19 (coronavirus) pandemic that was announced March 11, 2020, it is extremely timely to present a review of the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away.

In a weird twist of fate, the crisis in emerging infectious diseases is bringing the plight of the developing world to the attention of richer countries and world health organizations. Tests designed for developing countries are gaining in perceived value because they fulfill a huge need there, but also because they can be used to address the need of decentralized testing in resource poor areas in developed countries.

Thus not only is it imperative to have rapid and efficient tests for countries in the developing world, healthcare providers in developed countries can also benefit. The situation in developed countries is probably less urgent for the tropical diseases, but it is equally important to have better rapid tests for hepatitis, HIV, tuberculosis, and sexually transmissible diseases worldwide. To bolster developing countries' public health efforts, private and public funds are pouring dollars in to stem the tide of diseases such as HIV, tuberculosis, malaria, sexually transmissible diseases, and others.

Emerging Infectious Disease Diagnostics: Markets and Trends from Kalorama Information provides then an important addition to business planning to supplement infectious disease market research on known infectious diseases. As seen with the COVID-19 pandemic, business modeling based on current diseases alone would not capture the entire opportunity. Real-world estimates are of known threats, but as these estimates can only reflect current markets, the report also provides outlook assessments and analyzes the opportunity for emerging infections testing.

The report provides the following market information:

  • Markets for Emerging Infectious Diseases (Malaria, Lyme Disease, Chagas, Chikungunya, West Nile, Dengue Fever, Ebola, Zika, Others), 2019 and 2023 ($million)
  • Most Probable Threats, presenting the most known but yet still emerging diseases currently facing the healthcare systems of developing and increasingly developed nations
  • Current Diagnostic Tests for Emerging Diseases
  • Companies That Produce Emerging Disease Tests
  • Companies profiled in the report include:
  • altona Diagnostics
  • Arkray
  • Atomo Diagnostics
  • Bioneer
  • Chembio Diagnostics, Inc.
  • Coris BioConcept
  • CTK Biotech, Inc.
  • Luminex
  • MBio Diagnostics, Inc.
  • QIAGEN N.V.
  • Quest Diagnostics
  • Rheonix, Inc.
  • Thermo Fisher Scientific Inc.
  • Vela Diagnostics
*Note: The full report pricing option allows for 1-10 users in a single department*


  • The Next Epidemics?
    • Importance of Examining Infectious Disease
    • Most Probable Threats
      • Table Emerging Infectious Disease Threats by Region (Africa, L. America, N. America, SE Asia, W Europe, Eastern Europe, Mediterranean, W. Pacific)
    • Tests on the Market
      • Table Companies That Produce Emerging Disease Tests
    • COVID-19 and Emerging Diseases
      • Malaria and COVID-19
      • Chagas and COVID-19
      • Lyme Disease and COVID-19
      • Dengue Fever and COVID-19
    • WHO Expands Essential Diagnostics list
    • Emerging Diseases and the Developed World
  • Emerging Infectious Diseases and Tests
    • Table WHO Required Tests for Developing Countries
    • Diseases
      • Hepatitis
      • HIV
      • Respiratory Infections
      • Diarrheal Diseases
      • Tuberculosis
      • Malaria
      • Dengue Fever
      • Chagas Disease
      • Chikungunya virus (CHIKV)
      • Lyme Disease
      • Middle Eastern Respiratory Syndrome (MERS)
      • Nipah
      • Onchocerciasis
      • Leptospirosis
      • Rift Valley Fever
      • Hendra
      • Bird Flus
      • Other Diseases
    • Monitoring Efforts Pre COVID-19
    • How COVID-19 May Change Viral Monitoring
  • Markets for Emerging Infectious Diseases
    • Tests for Emerging Diseases
      • Table Selected Tests for Emerging Pathogens
    • Market Analysis
      • Table Markets for Emerging Infectious Diseases (Malaria, Lyme Disease, Chagas, Chikungunya, West Nile, Dengue Fever, Ebola, Zika, Others), 2019 and 2023 ($million)
      • Other Infections
    • Outlook for Emerging Infectious Diseases
  • Corporate Profiles
    • altona Diagnostics
      • COVID-19 Testing
    • Arkray
      • Company Overview
      • Infectious Disease
      • Diabetes
      • Dry Chemistry / Immunoassays
      • Urinalysis
      • Molecular
    • Atomo Diagnostics
      • Rapid COVID-19 Test
      • Integrated HCV Test for Self-Testing
      • HIV Self Test
    • Bioneer
      • AccuPower COVID-19 Real-Time RT-PCR Kit
      • Ebola
    • Chembio Diagnostics, Inc.
      • Company Overview
      • Products
    • Coris BioConcept
      • COVID-19 Testing
    • CTK Biotech, Inc.
      • Company Overview
      • Products
    • Luminex
      • Assay Development
      • Verigene Business
      • PCR
      • COVID-19 Testing
    • MBio Diagnostics, Inc.
      • Products
    • QIAGEN N.V.
      • Tuberculosis
      • Molecular Expansion
      • Molecular Microbiology
      • Digital PCR
      • Expansion
      • COVID-19 Testing
    • Quest Diagnostics
      • Products and Services
      • Key Acquisitions, Alliances, and Partnerships
      • COVID-19 Testing
    • Rheonix, Inc.
      • Products
    • Thermo Fisher Scientific Inc.
      • Molecular Test Business
      • qPCR
      • Zika Virus
      • COVID-19 Testing
    • Vela Diagnostics
      • COVID-19 Testing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook